
Aging Pathobiology and Therapeutics
Aging Pathobiology and Therapeutics (APT, Online ISSN 2690-1803) is an open access, peer-reviewed, interdisciplinary journal available online. The journal quarterly publishes research articles, reviews, editorials, case reports, opinions, letters, abstracts and drug therapeutic brief relating to research on Aging related diseases. The journal aims to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Aging Pathobiology and Therapeutics research. Scholars from the disciplines of geriatrics, gerontology, physiology, pathology, pharmacology, toxicology, biology, neuropsychology, psychology, nursing, epidemiology, and genetics are encouraged to contribute articles to the journal.
Editorial Board plays an important role in maintaining the quality and promote the development of a journal. The term of an Editorial Board member is 3 years with an option to be renewed.
Aging Pathobiology and Therapeutics has added a special issue column, and now we sincerely invite Guest Editors to join us.
Vol 3, No 1 (2021): Aging Pathobiology and Therapeutics is the latest issue of Aging Pathobiology and Therapeutics. Now it has published.
We kindly invite you to submit a manuscript for publication in Aging Pathobiology and Therapeutics (APT). The academic articles in the journal will be published online, through Open Access mode, and will be available worldwide freely and immediately, without restrictions.